Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
T cells in the control of organ-specific autoimmunity
Jeffrey A. Bluestone, Hélène Bour-Jordan, Mickie Cheng, Mark Anderson
Jeffrey A. Bluestone, Hélène Bour-Jordan, Mickie Cheng, Mark Anderson
View: Text | PDF
Review Series

T cells in the control of organ-specific autoimmunity

  • Text
  • PDF
Abstract

Immune tolerance is critical to the avoidance of unwarranted immune responses against self antigens. Multiple, non-redundant checkpoints are in place to prevent such potentially deleterious autoimmune responses while preserving immunity integral to the fight against foreign pathogens. Nevertheless, a large and growing segment of the population is developing autoimmune diseases. Deciphering cellular and molecular pathways of immune tolerance is an important goal, with the expectation that understanding these pathways will lead to new clinical advances in the treatment of these devastating diseases. The vast majority of autoimmune diseases develop as a consequence of complex mechanisms that depend on genetic, epigenetic, molecular, cellular, and environmental elements and result in alterations in many different checkpoints of tolerance and ultimately in the breakdown of immune tolerance. The manifestations of this breakdown are harmful inflammatory responses in peripheral tissues driven by innate immunity and self antigen–specific pathogenic T and B cells. T cells play a central role in the regulation and initiation of these responses. In this Review we summarize our current understanding of the mechanisms involved in these fundamental checkpoints, the pathways that are defective in autoimmune diseases, and the therapeutic strategies being developed with the goal of restoring immune tolerance.

Authors

Jeffrey A. Bluestone, Hélène Bour-Jordan, Mickie Cheng, Mark Anderson

×

Figure 1

Defects in both central and peripheral tolerance contribute to the development of autoimmunity.

Options: View larger image (or click on image) Download as PowerPoint
Defects in both central and peripheral tolerance contribute to the devel...
Left: In healthy individuals, most developing thymocytes with highly self-reactive TCRs are deleted during negative selection, while nonautoreactive cells mature and leave the thymus. Tregs are also selected on self antigens and express TCRs with higher affinity for self antigens than do Tconvs. The presentation of self antigens to developing thymocytes by Aire+ mTECs and thymic DCs is integral to the negative selection of autoreactive T cells and the generation of Tregs. Upon thymic selection, these Tregs migrate to the periphery, where they play a central role in maintaining peripheral tolerance, notably by controlling autoreactive T cells that escaped negative selection. Right: In contrast, in individuals with autoimmune diseases, Tregs demonstrate epigenetic, transcriptional, and functional features of instability that may result in loss of Foxp3 expression and suppressive function. These “ex-Foxp3” cells remain skewed toward autoreactivity and, in the absence of Foxp3 expression, can produce pro-inflammatory cytokines that may contribute to the pathological destruction of peripheral tissues. Moreover, Tregs are inefficient at controlling autoreactive T cells that escaped negative selection and are more prone to activation in the periphery due to defects in presentation of self antigens in the thymus.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts